Yahoo Finance sat down with CEOs in top industries, including healthcare, bitcoin mining, and cannabis. Below are highlights from this week's interviews.
Walgreens CEO Tim Wentworth (00:00:05)
Tim Wentworth, CEO of Walgreens (WBA), discusses the company's plans for 2024. “The story for 2024 is very clear. “It's a revitalization of the retail part of our business, both in the front and the back of the store,” Wentworth explains. “Secondly, So… get the balance sheet and cash position of the company.” “We're not moving from stores to a healthcare strategy, we're starting with great stores and expanding from there the range of services we can do across the healthcare ecosystem for payers,” Wentworth adds.
Eli Lilly CEO Dave Rex (00:00:54)
Dave Rex, CEO of Eli Lilly (LLY), explains what the company has seen in 2023, as well as what 2024 holds. “Last year was all about launching Zepbound, and the introduction happened in the fall… Mongaro had a great year,” says Rex. Also in diabetes. “I think this year is going to be about some new data releases. As we study these drugs, not only to prove that they lose weight, but what happens to your health overall. It's going to be an exciting decade to come for innovation in the weight loss space,” Rex adds.
CleanSpark CEO Zach Bradford (00:01:21)
Zach Bradford, CEO of CleanSpark (CLSK), discusses Bitcoin (BTC-USD) and Bitcoin ETF approval. “The power of Bitcoin depends in part on how many users are using it, what adoption looks like, what access looks like,” Bradford says. “Bitcoin-based ETFs help everyone also look at the related industries around them as something a little more friendly, a little more accessible for the everyday investor.”
Riot Platforms CEO Jason Lees (00:02:05)
Jason Liss, CEO of Riot Platforms (RIOT), explains why the immediate approval of Bitcoin ETFs is “a rising tide that will lift all boats in the industry.” “Historically, a lot of investors who might have had an interest in Bitcoin haven't been able to get exposure to the asset. Now with ETFs… these investors can have indirect exposure to Bitcoin and use that as part of their portfolio management,” Les notes. “We think this It will bring a huge influx of new capital into the space which should have a very positive catalyst for the price of Bitcoin.”
Tilray CEO Irwin Simon (00:02:48)
Irwin Simon, CEO of Tilray (TLRY), notes how the company is creating something “different” and “new.” “There aren't a lot of companies today that have medical cannabis, recreational cannabis, spirits and beer, medical distribution…so we're making something different, we're making something new,” Simon explains.
